Fig. 3.
Changes in LDL-C levels in a double-heterozygous FH patient after application of the PCSK9 antibody
She was diagnosed with FH at 37 years. CABG and aortic valve replacement were performed at 64 years.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.